{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:11:56Z","timestamp":1790907116968,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006012","name":"Christian Doppler Forschungsgesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012416","name":"Bundesministerium f\u00fcr Digitalisierung und Wirtschaftsstandort","doi-asserted-by":"publisher","award":["CD10271101"],"award-info":[{"award-number":["CD10271101"]}],"id":[{"id":"10.13039\/501100012416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010132","name":"\u00d6sterreichische Nationalstiftung f\u00fcr Forschung, Technologie und Entwicklung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.esmoop.2023.102048","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T08:11:33Z","timestamp":1700122293000},"page":"102048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prognosticators of survival in patients with metastatic pancreatic cancer and ascites"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1695-8577","authenticated-orcid":false,"given":"J.M.","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5264-8562","authenticated-orcid":false,"given":"L.","family":"Berchtold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Puhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4587-7901","authenticated-orcid":false,"given":"A.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Scheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.W.","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3541-2315","authenticated-orcid":false,"given":"M.","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Berghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0374-1408","authenticated-orcid":false,"given":"E.S.","family":"Bergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.esmoop.2023.102048_bib1","doi-asserted-by":"crossref","first-page":"dju413","DOI":"10.1093\/jnci\/dju413","article-title":"nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial","volume":"107","author":"Goldstein","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.esmoop.2023.102048_bib2","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.esmoop.2023.102048_bib3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MPA.0000000000001025","article-title":"Quality of life in patients with pancreatic cancer and their caregivers: a systematic review","volume":"47","author":"Bauer","year":"2018","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.esmoop.2023.102048_bib4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1089\/jpm.2021.0187","article-title":"Improving palliative care and quality of life in pancreatic cancer patients","volume":"25","author":"Chung","year":"2022","journal-title":"J\u00a0Palliat Med"},{"issue":"2","key":"10.1016\/j.esmoop.2023.102048_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101200","article-title":"Clinical risk factors for ascites in metastatic pancreatic cancer","volume":"8","author":"Berger","year":"2023","journal-title":"ESMO Open"},{"issue":"8","key":"10.1016\/j.esmoop.2023.102048_bib6","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/annonc\/mds178","article-title":"Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II\/III study comparing paracentesis plus catumaxomab with paracentesis alone","volume":"23","author":"Wimberger","year":"2012","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2023.102048_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl499","article-title":"Pattern and prognostic factors in patients with malignant ascites: a retrospective study","volume":"18","author":"Ayantunde","year":"2007","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2023.102048_bib8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00404-019-05071-6","article-title":"Patients\u2019 perspectives towards malignant ascites: results of a prospective observational trial regarding expectations, characteristics and quality of life-a study of the North-Eastern-German Society of Gynecological Oncology","volume":"299","author":"Armbrust","year":"2019","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.esmoop.2023.102048_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/1097-0142(19890801)64:3<753::AID-CNCR2820640330>3.0.CO;2-Y","article-title":"Malignant ascites of unknown origin","volume":"64","author":"Ringenberg","year":"1989","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2023.102048_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/clon.2002.0135","article-title":"The current and future management of malignant ascites","volume":"15","author":"Smith","year":"2003","journal-title":"Clin Oncol"},{"key":"10.1016\/j.esmoop.2023.102048_bib11","doi-asserted-by":"crossref","first-page":"v56","DOI":"10.1093\/annonc\/mdv295","article-title":"Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Ducreux","year":"2015","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2023.102048_bib12","article-title":"The ALBI score: from liver function in patients with HCC to a general measure of liver function","volume":"4","author":"Toyoda","year":"2022","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.esmoop.2023.102048_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing - when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.102048_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1699-0463.1953.tb04805.x","article-title":"Pathogenesis of ascites in peritoneal carcinomatosis","volume":"33","author":"Holm-Nielsen","year":"1953","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"11","key":"10.1016\/j.esmoop.2023.102048_bib15","first-page":"2631","article-title":"Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation","volume":"53","author":"Nagy","year":"1993","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.esmoop.2023.102048_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10434-999-0373-0","article-title":"Markedly elevated levels of vascular endothelial growth factor in malignant ascites","volume":"6","author":"Zebrowski","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"10.1016\/j.esmoop.2023.102048_bib17","first-page":"5721","article-title":"Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model","volume":"9","author":"Byrne","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.esmoop.2023.102048_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0748-7983(96)80009-6","article-title":"Malignant ascites: a 2-year review from a teaching hospital","volume":"22","author":"Parsons","year":"1996","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2023.102048_bib19","first-page":"474","article-title":"Malignant ascites: demographics, therapeutic efficacy and predictors of survival","volume":"6","author":"Mackey","year":"1996","journal-title":"Can J Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.102048_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12885-017-3925-x","article-title":"Colorectal cancer liver metastases - a population-based study on incidence, management and survival","volume":"18","author":"Engstrand","year":"2018","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.esmoop.2023.102048_bib21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2023.102048_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00535-007-2134-9","article-title":"Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival","volume":"43","author":"Changchien","year":"2008","journal-title":"J\u00a0Gastroenterol"},{"issue":"6","key":"10.1016\/j.esmoop.2023.102048_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/MPA.0000000000001857","article-title":"Incidence, treatment, and survival of synchronous peritoneal metastases in pancreatic cancer: update of a Nationwide cohort","volume":"50","author":"Rijken","year":"2021","journal-title":"Pancreas"},{"issue":"7","key":"10.1016\/j.esmoop.2023.102048_bib24","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.4103\/jcrt.JCRT_500_20","article-title":"Portal hypertension caused by pancreatic cancer: multidetector computed tomography diagnosis and multivariate analysis of variceal hemorrhage","volume":"16","author":"Liu","year":"2020","journal-title":"J\u00a0Cancer Res Ther"},{"issue":"18","key":"10.1016\/j.esmoop.2023.102048_bib25","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3748\/wjg.v13.i18.2535","article-title":"Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes","volume":"13","author":"Harmanci","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.esmoop.2023.102048_bib26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/liv.13988","article-title":"Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: the more, the worse?","volume":"39","author":"M\u00e4hringer-Kunz","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.esmoop.2023.102048_bib27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.esmoop.2023.102048_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2018.12.007","article-title":"NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors","volume":"108","author":"Wang-Gillam","year":"2019","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2023.102048_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/1354750X.2021.1893814","article-title":"Readily available biomarkers predict poor survival in metastatic pancreatic cancer","volume":"26","author":"Strijker","year":"2021","journal-title":"Biomarkers"},{"issue":"11","key":"10.1016\/j.esmoop.2023.102048_bib30","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2023.102048_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.lungcan.2017.07.003","article-title":"Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: comparative study of normal lung, emphysema, and pulmonary fibrosis","volume":"111","author":"Miura","year":"2017","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2023.102048_bib32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.bjc.6606087","article-title":"An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study","volume":"104","author":"Proctor","year":"2011","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2023.102048_bib33","article-title":"ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma","volume":"3","author":"Demirtas","year":"2021","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.esmoop.2023.102048_bib34","first-page":"1","article-title":"Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer","volume":"62","author":"Dedrick","year":"1978","journal-title":"Cancer Treat Rep"},{"issue":"2","key":"10.1016\/j.esmoop.2023.102048_bib35","article-title":"Ascites and resistance to immune checkpoint inhibition in dMMR\/MSI-H metastatic colorectal and gastric cancers","volume":"10","author":"Fuc\u00e0","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"issue":"8","key":"10.1016\/j.esmoop.2023.102048_bib36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9930","key":"10.1016\/j.esmoop.2023.102048_bib37","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","article-title":"Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial","volume":"383","author":"Zimmermann","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.esmoop.2023.102048_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.21037\/apm.2019.02.07","article-title":"Early palliative care and quality of life of advanced cancer patients-a multicenter randomized clinical trial","volume":"8","author":"Franciosi","year":"2019","journal-title":"Ann Palliat Med"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923012899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923012899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:33:49Z","timestamp":1761856429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702923012899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2059702923012899"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.102048","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognosticators of survival in patients with metastatic pancreatic cancer and ascites","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.102048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102048"}}